secwatch / observer
8-K filed May 2, 2023, 7:59 PM ET CIK 0001831874
leadership confidence high sentiment neutral materiality 0.30

Iris Acquisition Corp: Nasdaq/NYSE listing notice — Iris Acquisition Corp director resigns, triggering Nasdaq audit committee non-compliance

Iris Acquisition Corp

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Shahibhushan Borade

Director
Iris Acquisition Corp
Effective
2023-04-26
Filed
May 2, 2023, 7:59 PM ET
On April 26, 2023, Dr. Borade, an Audit Committee member, notified the Company of his intent to resign as a member of the Board effective April 26, 2023.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.7

Iris Acquisition Corp received a nasdaq deficiency notice notice regarding other.

Exchange
nasdaq
Notice
deficiency notice
Exact text from the filing
May 2, 2023, Iris Acquition Corp (the “Company”) notified the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that as a result of the resignation of Shahibhushan Borade (“Dr. Borade”) from the Company’s board of directors (the “Board”) (as described below in
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Shahibhushan Borade resigned as Director at Iris Acquisition Corp.

Action
resigned
Role
Director
Exact text from the filing
On April 26, 2023, Dr. Borade, an Audit Committee member, notified the Company of his intent to resign as a member of the Board effective April 26, 2023.
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001104659-23-055046
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.